The potential effect of the tumour necrosis factor-α inhibitors on vitamin D status in psoriatic patients.
Dermatology Clinic, Polytechnic University of Marche, , Italy. giulia.ganzetti@alice.it.
Giulia
G
Ganzetti
Anna
A
Campanati
Vitangelo
V
Scocco
Marina
M
Brugia
Massimo
M
Tocchini
Giulia
G
Liberati
Katia
K
Giuliodori
Valerio
V
Brisigotti
Annamaria
A
Offidani
D000328:Adult; D015415:Biomarkers / Q000097:blood; D002118:Calcium / Q000097:blood; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood; D011565:Psoriasis / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D014807:Vitamin D / Q000097:blood*
D015415:Biomarkers; D007166:Immunosuppressive Agents; C470125:PTH protein, human; D010281:Parathyroid Hormone; D014409:Tumor Necrosis Factor-alpha; D014807:Vitamin D; D002118:Calcium